Page last updated: 2024-12-10

1,8-dihydroxy-3,7-dimethoxyxanthone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,8-dihydroxy-3,7-dimethoxyxanthone, also known as **mangiferin**, is a naturally occurring compound found in various plants, most notably the mango tree.

**Here's what makes it important for research:**

* **Pharmacological Activities:** Mangiferin has shown promising therapeutic potential across a wide range of medical fields.
* **Antioxidant:** It is a potent antioxidant, protecting cells from damage caused by free radicals.
* **Anti-inflammatory:** Mangiferin has anti-inflammatory properties that could be helpful in treating conditions like arthritis and inflammatory bowel disease.
* **Antidiabetic:** Studies suggest it may improve glucose tolerance and insulin sensitivity, potentially aiding in diabetes management.
* **Anti-cancer:** Mangiferin has shown some anticancer activity, inhibiting the growth and proliferation of cancer cells.
* **Neuroprotective:** It may protect the nervous system from damage and could have implications for treating neurological disorders like Alzheimer's and Parkinson's diseases.
* **Antiviral:** Mangiferin exhibits antiviral activity against some viruses, including the influenza virus.

* **Research Focus Areas:** Mangiferin's diverse pharmacological activities have made it a subject of intense research interest. Scientists are exploring its potential as:
* **Drug candidate:** Researchers are investigating how to utilize mangiferin in the development of new medications for a range of diseases.
* **Functional food ingredient:** Its antioxidant and anti-inflammatory properties make it attractive for use in functional foods and supplements.
* **Pharmaceutical excipient:** Mangiferin's potential as an excipient (a substance used to improve the formulation of medicines) is being explored.

**Challenges and Future Directions:**

While mangiferin shows promise, further research is needed to:

* **Understand its mechanism of action:** Researchers are working to clarify how mangiferin exerts its effects at the molecular level.
* **Improve its bioavailability:** Mangiferin's poor bioavailability (its ability to reach the bloodstream) is a challenge that needs to be overcome for it to be effectively used in medicine.
* **Develop safe and effective delivery systems:** Finding suitable ways to deliver mangiferin to target tissues is crucial for its therapeutic application.

In conclusion, 1,8-dihydroxy-3,7-dimethoxyxanthone (mangiferin) is a fascinating natural compound with a wide range of potential therapeutic applications. Ongoing research aims to unlock its full potential and translate its promising properties into effective treatments for various diseases.

1,8-dihydroxy-3,7-dimethoxyxanthone: isolated from Gentianopsis paludosa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-O-methylswertianin : A member of the class of xanthones that is swertianin in which the hydroxy group at position 2 has been replaced by a methoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Gentianopsisgenus[no description available]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]
Gentianopsis paludosaspecies[no description available]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID5281653
CHEMBL ID3704820
CHEBI ID1228
SCHEMBL ID18240046
MeSH IDM0485193

Synonyms (27)

Synonym
2-o-methylswertianin
1,8-dihydroxy-2,6-dimethoxyxanthone
22172-17-4
methylswertianin
swertiaperennin
brn 1351740
9h-xanthen-9-one, 1,8-dihydroxy-2,6-dimethoxy-
1,8-dihydroxy-2,6-dimethoxy-9h-xanthen-9-one
xanthen-9-one, 1,8-dihydroxy-2,6-dimethoxy-
1,8-dihydroxy-2,6-dimethoxyxanthen-9-one
AKOS016013391
CHEMBL3704820
SCHEMBL18240046
1,8-dihydroxy-3,7-dimethoxyxanthone
CHEBI:1228
AC-34321
Q-100281
1,8-dihydroxy-2,6-dimethoxy-xanthen-9-one
FT-0698038
DTXSID50176709
us9114126, 2027ba2
bdbm174836
swertiaperrenin
HY-N1995
Q27105429
CS-0018316
XAA17217
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
xanthonesAny member of the class of xanthenes based on a xanthone skeleton.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]